Abstract
Many age-related diseases are associated with metabolic abnormalities, and dietary interventions may have some benefit in alleviating symptoms or in delaying disease onset. Here, we review the commonly used best practices involved in applications of the ketogenic diet to facilitate its translation into clinical use. The findings reveal that better education of physicians is essential for applying the optimum diet and monitoring its effects in clinical practice. In addition, investigators should carefully consider potential confounding factors prior to commencing studies involving a ketogenic diet. Most importantly, current studies should improve their reporting on ketone levels as well as on the intake of both macro- and micronutrients. Finally, more detailed studies on the mechanism of action are necessary to help identify potential biomarkers for response prediction and monitoring, and to uncover new drug targets to aid the development of novel treatments.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Balasubramanian P, Howell PR, Anderson RM (2017) Aging and caloric restriction research: a biological perspective with translational potential. EBioMedicine 21:37–44
Meidenbauer JJ, Ta N, Seyfried TN (2014) Influence of a ketogenic diet, fish-oil, and calorie restriction on plasma metabolites and lipids in C57BL/6J mice. Nutr Metab (Lond) 11:23. https://doi.org/10.1186/1743-7075-11-23
Roberts MN, Wallace MA, Tomilov AA, Zhou Z, Marcotte GR, Tran D et al (2017) A ketogenic diet extends longevity and healthspan in adult mice. Cell Metab 26(3):539–546.e5. https://doi.org/10.1016/j.cmet.2017.08.005
Newman JC, Verdin E (2017) β-Hydroxybutyrate: a signaling metabolite. Annu Rev Nutr 37:51–76
Scheibye-Knudsen M, Mitchell SJ, Fang EF, Iyama T, Ward T, Wang J et al (2014) A high-fat diet and NAD+ activate Sirt1 to rescue premature aging in cockayne syndrome. Cell Metab 20(5):840–855
Weber DD, Aminazdeh-Gohari S, Kofler B (2018) Ketogenic diet in cancer therapy. Aging (Albany NY) 10(2):164–165
Seyfried TN (2014) Ketone strong: emerging evidence for a therapeutic role of ketone bodies in neurological and neurodegenerative diseases. J Lipid Res 55(9):1815–1817
Bough KJ, Rho JM (2007) Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 48(1):43–58
Shilpa J, Mohan V (2018) Ketogenic diets: boon or bane? Indian J Med Res 148(3):251–253
Hartman AL, Gasior M, Vining EP, Rogawski MA (2007) The neuropharmacology of the ketogenic diet. Pediatr Neurol 36(5):281–292
Paoli A, Rubini A, Volek JS, Grimaldi KA (2013) Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur J Clin Nutr 67(8):789–796
Seyfried TN, Mukherjee P (2005) Targeting energy metabolism in brain cancer: review and hypothesis. Nutr Metab (Lond) 2:30. https://doi.org/10.1186/1743-7075-2-30
Stafstrom CE, Rho JM (2012) The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol 3:59. https://doi.org/10.3389/fphar.2012.00059
Kossoff EH, Andermann F (2010) Migraine and epilepsy. Semin Pediatr Neurol 17(2):117–122
Maggioni F, Margoni M, Zanchin G (2011) Ketogenic diet in migraine treatment: a brief but ancient history. Cephalalgia 31(10):1150–1151
PACHECO A, WS EASTERLING, MW PRYER (1965) A pilot study of the ketogenic diet in schizophrenia. Am J Psychiatry 121:1110–1111
Pulsifer MB, Gordon JM, Brandt J, Vining EP, Freeman JM (2001) Effects of ketogenic diet on development and behavior: preliminary report of a prospective study. Dev Med Child Neurol 43(5):301–306
Barañano KW, Hartman AL (2008) The ketogenic diet: uses in epilepsy and other neurologic illnesses. Curr Treat Options Neurol 10(6):410–419
Kraft BD, Westman EC (2009) Schizophrenia, gluten, and low-carbohydrate, ketogenic diets: a case report and review of the literature. Nutr Metab (Lond) 6:10. https://doi.org/10.1186/1743-7075-6-10
Palmer CM (2017) Ketogenic diet in the treatment of schizoaffective disorder: two case studies. Schizophr Res 189:208–209
Taylor MK, Sullivan DK, Mahnken JD, Burns JM, Swerdlo RH (2018) Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer’s disease. Alzheimers Dement 4:28–36
Żarnowska I, Chrapko B, Gwizda G, Nocuń A, Mitosek-Szewczyk K, Gasior M (2018) Therapeutic use of carbohydrate-restricted diets in an autistic child; a case report of clinical and 18FDG PET findings. Metab Brain Dis 33(4):1187–1192
Paoli A, Bosco G, Camporesi EM, Mangar D (2015) Ketosis, ketogenic diet and food intake control: a complex relationship. Front Psychol 6:27. https://doi.org/10.3389/fpsyg.2015.00027
Nyenwe EA, Kitabchi AE (2016) The evolution of diabetic ketoacidosis: an update of its etiology, pathogenesis and management. Metabolism 65(4):507–521
Umpierrez G, Korytkowski M (2016) Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol 12(4):222–232
Krebs HA (1966) The regulation of the release of ketone bodies by the liver. Adv Enzym Regul 4:339–354
Kossoff EH, Zupec-Kania BA, Auvin S, Ballaban-Gil KR, Christina Bergqvist AG, Practice Committee of the Child Neurology et al (2018) Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the international ketogenic diet study group. Epilepsia Open 3(2):175–192
Matthew Charles Lee Phillips (2019) Ketogenic diet therapies in children and adults with epilepsy. In: Epilepsy – advances in diagnosis and therapy. https://www.intechopen.com/online-first/ketogenic-diet-therapies-in-children-and-adults-with-epilepsy
Roehl K, Sewak SL (2017) Practice paper of the academy of nutrition and dietetics: classic and modified ketogenic diets for treatment of epilepsy. J Acad Nutr Diet 117(8):1279–1292
Wibisono C, Rowe N, Beavis E, Kepreotes H, Mackie FE, Lawson JA et al (2015) Ten-year single-center experience of the ketogenic diet: factors influencing efficacy, tolerability, and compliance. J Pediatr 166(4):1030–6.e1. https://doi.org/10.1016/j.jpeds.2014.12.018
Wirrell E, Eckert S, Wong-Kisiel L, Payne E, Nickels K (2018) Ketogenic diet therapy in infants: efficacy and tolerability. Pediatr Neurol 82:13–18
Wheless JW (2001) The ketogenic diet: an effective medical therapy with side effects. J Child Neurol 16(9):633–635
Kang HC, Chung DE, Kim DW, Kim HD (2004) Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia 45(9):1116–1123
Phelps JR, Siemers SV, El-Mallakh RS (2013) The ketogenic diet for type II bipolar disorder. Neurocase 19(5):423–426
Scott JM, Deuster PA (2017) Ketones and human performance. J Spec Oper Med 17(2):112–116
Masood W, Uppaluri KR (2019) Ketogenic diet. StatPearls. StatPearls Publishing LLC, Treasure Island, FL. https://www.ncbi.nlm.nih.gov/books/NBK499830/
Kekwick A, Pawan GL, Chalmers TM (1959) Resistance to ketosis in obese subjects. Lancet 2(7113):1157–1159
Paoli A, Cenci L, Fancelli M, Parmagnani A, Fratter A, Cucchi A et al (2010) Ketogenic diet and phytoextracts comparison of the efficacy of Mediterranean, zone and tisanoreica diet on some health risk factors. Agro Food Industry Hi Tech 21(4):24–29
Cahill GF Jr, Herrera MG, Morgan AP, Soeldner JS, Steinke J, Levy PL et al (1966) Hormone-fuel interrelationships during fasting. J Clin Invest 45(11):1751–1769
Reichard GA Jr, Owen OE, Haff AC, Paul P, Bortz WM (1974) Ketone-body production and oxidation in fasting obese humans. J Clin Invest 53(2):508–515
Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GFJ (1967) Brain metabolism during fasting. J Clin Invest 46(10):1589–1595
Owen OE, Felig P, Morgan AP, Wahren J, Cahill GF Jr (1969) Liver and kidney metabolism during prolonged starvation. J Clin Invest 48(3):574–583
Cahill GF Jr (2006) Fuel metabolism in starvation. Annu Rev Nutr 26:1–22
Veech RL (2004) The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 70(3):309–319
Güntner AT, Kompalla JF, Landis H, Theodore SJ, Geidl B, Sievi NA et al (2018) Guiding ketogenic diet with breath acetone sensors. Sensors (Basel) 18(11):pii: E3655. https://doi.org/10.3390/s18113655
Lee RWY, Corley MJ, Pang A, Arakaki G, Abbott L, Nishimoto M et al (2018) A modified ketogenic gluten-free diet with MCT improves behavior in children with autism spectrum disorder. Physiol Behav 188:205–211
Barnard DE, Lewis SM, Teter BB, Thigpen JE (2009) Open- and closed-formula laboratory animal diets and their importance to research. J Am Assoc Lab Anim Sci 48(6):709–713
Franklin CL, Ericsson AC (2017) Microbiota and reproducibility of rodent models. Lab Anim (NY) 46(4):114–122
Ye F, Li XJ, Jiang WL, Sun HB, Liu J (2015) Efficacy of and patient compliance with a ketogenic diet in adults with intractable epilepsy: a meta-analysis. J Clin Neurol 11(1):26–31
Kraeuter AK, Loxton H, Lima BC, Rudd D, Sarnyai Z (2015) Ketogenic diet reverses behavioral abnormalities in an acute NMDA receptor hypofunction model of schizophrenia. Schizophr Res 169(1–3):491–493
Kraeuter AK, van den Buuse M, Sarnyai Z (2019) Ketogenic diet prevents impaired prepulse inhibition of startle in an acute NMDA receptor hypofunction model of schizophrenia. Schizophr Res 206:244–250
Peet M (2008) Omega-3 polyunsaturated fatty acids in the treatment of schizophrenia. Isr J Psychiatry Relat Sci 45(1):19–25
Alqarni A, Mitchell TW, McGorry PD, Nelson B, Markulev C, Yuen HP et al (2019) Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people. Schizophr Res 2019:pii: S0920-9964(19)30241-5. https://doi.org/10.1016/j.schres.2019.06.020
Schlögelhofer M, Amminger GP, Schaefer MR, Fusar-Poli P, Smesny S, McGorry P et al (2014) Polyunsaturated fatty acids in emerging psychosis: a safer alternative? Early Interv Psychiatry 8(3):199–208
Mitchell ES, Conus N, Kaput J (2014) B vitamin polymorphisms and behavior: evidence of associations with neurodevelopment, depression, schizophrenia, bipolar disorder and cognitive decline. Neurosci Biobehav Rev 47:307–320
Feinman RD, Pogozelski WK, Astrup A, Bernstein RK, Fine EJ, Westman EC et al (2015) Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. Nutrition 31(1):1–13
Barzegar M, Afghan M, Tarmahi V, Behtari M, Rahimi Khamaneh S, Raeisi S (2019) Ketogenic diet: overview, types, and possible anti-seizure mechanisms. Nutr Neurosci 26:1–10
Van der Auwera I, Wera S, Van Leuven F, Henderson ST (2005) A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer’s disease. Nutr Metab (Lond) 2:28. https://doi.org/10.1186/1743-7075-2-28
Ruskin DN, Ross JL, Kawamura M Jr, Ruiz TL, Geiger JD, Masino SA (2011) A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1J mouse model of Huntington’s disease. Physiol Behav 103(5):501–507
Beckett TL, Studzinski CM, Keller JN, Paul Murphy M, Niedowicz DM (2013) A ketogenic diet improves motor performance but does not affect beta-amyloid levels in a mouse model of Alzheimer’s disease. Brain Res 1505:61–67
Kim DY, Hao J, Liu R, Turner G, Shi FD, Rho JM (2012) Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis. PLoS One 7(5):e35476. https://doi.org/10.1371/journal.pone.0035476
Ahn Y, Narous M, Tobias R, Rho JM, Mychasiuk R (2014) The ketogenic diet modifies social and metabolic alterations identified in the prenatal valproic acid model of autism spectrum disorder. Dev Neurosci 36(5):371–380
Choi IY, Piccio L, Childress P, Bollman B, Ghosh A, Brandhorst S et al (2016) A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms. Cell Rep 15(10):2136–2146
Smith J, Rho JM, Teskey GC (2016) Ketogenic diet restores aberrant cortical motor maps and excitation-to-inhibition imbalance in the BTBR mouse model of autism spectrum disorder. Behav Brain Res 304:67–70
Newell C, Bomhof MR, Reimer RA, Hittel DS, Rho JM, Shearer J (2016) Ketogenic diet modifies the gut microbiota in a murine model of autism spectrum disorder. Mol Autism 7(1):37. https://doi.org/10.1186/s13229-016-0099-3
Mychasiuk R, Rho JM (2017) Genetic modifications associated with ketogenic diet treatment in the BTBR(T+Tf/J) mouse model of autism spectrum disorder. Autism Res 10(3):456–471
Ruskin DN, Murphy MI, Slade SL, Masino SA (2017) Ketogenic diet improves behaviors in a maternal immune activation model of autism spectrum disorder. PLoS One 12(2):e0171643. https://doi.org/10.1371/journal.pone.0171643
Cheng B, Yang X, An L, Gao B, Liu X, Liu S (2009) Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson’s disease. Brain Res 1286:25–31
Murphy P, Likhodii SS, Hatamian M, McIntyre Burnham W (2005) Effect of the ketogenic diet on the activity level of Wistar rats. Pediatr Res 57(3):353–357
Murphy P, Burnham WM (2006) The ketogenic diet causes a reversible decrease in activity level in long-Evans rats. Exp Neurol 201(1):84–89
Sussman D, Germann J, Henkelman M (2015) Gestational ketogenic diet programs brain structure and susceptibility to depression & anxiety in the adult mouse offspring. Brain Behav 5(2):e00300. https://doi.org/10.1002/brb3.300
Zhao Z, Lange DJ, Voustianiouk A, MacGrogan D, Ho L, Suh J et al (2006) A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci 7:29. https://doi.org/10.1186/1471-2202-7-29
Verpeut JL, DiCicco-Bloom E, Bello NT (2016) Ketogenic diet exposure during the juvenile period increases social behaviors and forebrain neural activation in adult engrailed 2 null mice. Physiol Behav 161:90–98
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Kraeuter, AK., Guest, P.C., Sarnyai, Z. (2020). Protocol for the Use of the Ketogenic Diet in Preclinical and Clinical Practice. In: Guest, P. (eds) Clinical and Preclinical Models for Maximizing Healthspan. Methods in Molecular Biology, vol 2138. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0471-7_4
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0471-7_4
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0470-0
Online ISBN: 978-1-0716-0471-7
eBook Packages: Springer Protocols